$Characteristics of patients with heart failure with preserved ejection fraction in primary care: Cross-sectional analysis$

Characteristics of patients with heart failure with preserved ejection fraction in primary care: Cross-sectional analysis

Background Many patients with heart failure with preserved ejection fraction (HFpEF) are undiagnosed, and UK general practice registers do not typically record HF sub-type. Improvements in management of HFpEF is dependent on improved identification and characterisation of patients in primary care....

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	Forsyth, F, Brimicombe, J, Cheriyan, J, Edwards, D, Hobbs, R, Jalaludeen, N, Mant, J, Pilling, M, Schiff, R, Taylor, C, Zaman, MJ, Deaton, C
Fformat:	Journal article
Iaith:	English
Cyhoeddwyd:	Royal College of General Practitioners 2021

Eitemau Tebyg

Diagnosis of patients with heart failure with preserved ejection fraction in primary care: cohort study
gan: Forsyth, F, et al.
Cyhoeddwyd: (2021)

Diagnosis of patients with heart failure with preserved ejection fraction in primary care: cohort study
gan: Faye Forsyth, et al.
Cyhoeddwyd: (2021-12-01)

Characteristics of patients with heart failure with preserved ejection fraction in primary care: a cross-sectional analysis
gan: Faye Forsyth, et al.
Cyhoeddwyd: (2021-11-01)

Optimising management of patients with heart failure with preserved ejection fraction in primary care (OPTIMISE-HFpEF): rationale and protocol for a multi-method study
gan: Forsyth, F, et al.
Cyhoeddwyd: (2019)

The tip of the iceberg: finding patients with heart failure with preserved ejection fraction in primary care. An observational study
gan: Christi Deaton, et al.
Cyhoeddwyd: (2018-09-01)

Prevalence of heart failure preserved ejection fraction in the community
gan: Mahadevan, G, et al.
Cyhoeddwyd: (2007)

Understanding the management of heart failure with preserved ejection fraction: a qualitative multiperspective study
gan: Sowden, E, et al.
Cyhoeddwyd: (2020)

Heart failure with preserved ejection fraction
gan: Harper, A, et al.
Cyhoeddwyd: (2018)

Biomarkers in Heart Failure with Preserved Ejection Fraction
gan: Antoni Bayes-Genis, et al.
Cyhoeddwyd: (2022-06-01)

Heart failure with preserved ejection fraction – onset
gan: Branimir Kanazirev
Cyhoeddwyd: (2021-07-01)

Treatment of heart failure with preserved ejection fraction
gan: Alfredo Monteverde, et al.
Cyhoeddwyd: (2018-06-01)

Inflammation as a therapeutic target in heart failure with preserved ejection fraction
gan: Zhen Hui Peh, et al.
Cyhoeddwyd: (2023-06-01)

Retrospective analysis of SGLT2 inhibitors in heart failure with preserved ejection fraction
gan: John S. Clemmer, et al.
Cyhoeddwyd: (2023-06-01)

The Gut Microbiome of Heart Failure With Preserved Ejection Fraction
gan: Anna L. Beale, et al.
Cyhoeddwyd: (2021-07-01)

Nitric Oxide Signaling in Heart Failure With Preserved Ejection Fraction
gan: Lucas Cruz, MD, et al.
Cyhoeddwyd: (2017-06-01)

Prognostic Value of Anxiety Between Heart Failure With Reduced Ejection Fraction and Heart Failure With Preserved Ejection Fraction
gan: Tin‐Kwang Lin, et al.
Cyhoeddwyd: (2019-06-01)

Profile of sleep disordered breathing in heart failure with preserved ejection fraction
gan: Nitesh Gupta, et al.
Cyhoeddwyd: (2020-11-01)

NADPH Oxidases in Diastolic Dysfunction and Heart Failure with Preserved Ejection Fraction
gan: James P. Teuber, et al.
Cyhoeddwyd: (2022-09-01)

Myocardial Metabolism in Heart Failure with Preserved Ejection Fraction
gan: Henry, JA, et al.
Cyhoeddwyd: (2024)

Dietary Interventions in Heart Failure With Preserved Ejection Fraction
gan: Hayley E. Billingsley, PhD, RDN, et al.
Cyhoeddwyd: (2025-01-01)

Cell Therapy in Heart Failure with Preserved Ejection Fraction
gan: Sabina Frljak, et al.
Cyhoeddwyd: (2022-03-01)

Principles for diagnosing heart failure with preserved ejection fraction
gan: N. E. Shirokov, et al.
Cyhoeddwyd: (2023-09-01)

Contractile Reserve in Heart Failure with Preserved Ejection Fraction
gan: Daniela Di Lisi, et al.
Cyhoeddwyd: (2022-08-01)

Cell Therapy for Heart Failure With Preserved Ejection Fraction∗
gan: Barry A. Borlaug, MD, et al.
Cyhoeddwyd: (2016-01-01)

Clinical Phenotypes in Heart Failure With Preserved Ejection Fraction
gan: Rohan Samson, et al.
Cyhoeddwyd: (2016-01-01)

Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction
gan: Domenico D’Amario, et al.
Cyhoeddwyd: (2019-11-01)

Sex Differences in Heart Failure With Preserved Ejection Fraction
gan: Yohei Sotomi, et al.
Cyhoeddwyd: (2021-03-01)

Sarcopenic Obesity in Heart Failure With Preserved Ejection Fraction
gan: Danielle L. Kirkman, et al.
Cyhoeddwyd: (2020-09-01)

Microvascular Rarefaction and Heart Failure With Preserved Ejection Fraction
gan: Heng Zeng, et al.
Cyhoeddwyd: (2019-02-01)

Genetic architecture of heart failure with preserved versus reduced ejection fraction
gan: Jacob Joseph, et al.
Cyhoeddwyd: (2022-12-01)

Intentional weight loss as a novel treatment for heart failure with preserved ejection fraction
gan: Hundertmark, MJ, et al.
Cyhoeddwyd: (2021)

Heart Failure with Preserved Ejection Fraction: Time to Revisit the Stiff Heart
gan: Juan R. Vilaro, et al.
Cyhoeddwyd: (2019-01-01)

Diastolic Ventricular Interaction in Heart Failure With Preserved Ejection Fraction
gan: Sathish K. Parasuraman, et al.
Cyhoeddwyd: (2019-04-01)

Pirfenidone in heart failure with preserved ejection fraction—rationale and design of the PIROUETTE trial
gan: Lewis, G, et al.
Cyhoeddwyd: (2019)

Resting and exercise haemodynamic characteristics of patients with advanced heart failure and preserved ejection fraction
gan: T. Deis, et al.
Cyhoeddwyd: (2022-02-01)

The Role of Systemic Microvascular Dysfunction in Heart Failure with Preserved Ejection Fraction
gan: Jerremy Weerts, et al.
Cyhoeddwyd: (2022-02-01)

Prognostic Significance of Baseline Serum Sodium in Heart Failure With Preserved Ejection Fraction
gan: Yash R. Patel, et al.
Cyhoeddwyd: (2018-06-01)

Clinical and echocardiographic characteristics and cardiovascular outcomes according to diabetes status in patients with heart failure and preserved ejection fraction. A report from the Irbesartan in Heart Failure with Preserved Ejection Fraction trial (I-Preserve)
gan: Kristensen, S, et al.
Cyhoeddwyd: (2017)

Clinical Characteristics and Prognosis of Heart Failure with Preserved Ejection Fraction Across Diverse Ejection Fraction Ranges
gan: Jingjing Su, et al.
Cyhoeddwyd: (2024-05-01)

Microvascular disease and heart failure with reduced and preserved ejection fraction in type 2 diabetes
gan: Ify R. Mordi, et al.
Cyhoeddwyd: (2020-06-01)